Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview

Immunotherapy is a promising therapeutic strategy both for solid and hematologic tumors, such as in Hodgkin (HL) and non-Hodgkin lymphoma (NHL). In particular, immune-checkpoint inhibitors, such as nivolumab and pembrolizumab, are increasingly used for the treatment of refractory/relapsed HL. At the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Pers Med
Huvudupphovsmän: Ferrari, Cristina, Maggialetti, Nicola, Masi, Tamara, Nappi, Anna Giulia, Santo, Giulia, Niccoli Asabella, Artor, Rubini, Giuseppe
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2021
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8002936/
https://ncbi.nlm.nih.gov/pubmed/33803667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11030217
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk